Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05711446 · ClinicalTrials.gov registry record · NA
Double Voiding and Post-transplant UTI
A NA study of Urinary Tract Infections and Kidney Transplant; Complications, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 438
- Enrollment target
- 1
- Study location
NCT05711446: Recruiting NA study of Urinary Tract Infections and Kidney Transplant; Complications, sponsored by Weill Medical College of Cornell University.
NCT05711446 is a NA study of Urinary Tract Infections and Kidney Transplant; Complications that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 438 participants, roughly in line with the 445-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05711446, a NA study of Urinary Tract Infections and Kidney Transplant; Complications, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 438 participants
- Enrollment target
- 1
- Study location
Study Summary
Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.
Primary Outcome
UTI will be defined as a clean catch urine bacterial culture that is reported as anything other than "\<1000 CFU/ml (Colony Forming Unit / Milliliter)- Negative". Clean catch urine cultures are done at each follow-up visit as a standard of care, irrespective of patient symptoms. Hence the outcome will include both asymptomatic and symptomatic UTIs.
Conditions Studied
Interventions
- OTHER Double Voiding
- OTHER Regular Voiding
Study Locations (1)
New York
- Weill Cornell Medical College / NY Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2023-04-07 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05711446 shows while recruiting
NCT05711446 is an interventional study that assigns participants to a tested intervention. The registered 438 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 445-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target.
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Double Voiding is the first listed.
NCT05711446 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05711446 about?
NCT05711446 is a clinical study titled "Double Voiding and Post-transplant UTI". Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the ris...
What is the current status of trial NCT05711446?
This trial is currently recruiting. It is a NA study. The enrollment target is 438 participants. The study started on 2023-04-07. Estimated completion is 2026-12.
What conditions does trial NCT05711446 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Kidney Transplant; Complications.
What interventions are being tested in trial NCT05711446?
The interventions under investigation include: Double Voiding (OTHER), Regular Voiding (OTHER).
Who is sponsoring clinical trial NCT05711446?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05711446 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05711446's enrollment target sits among peer trials
438 10th of 34 higher than 25 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
-
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI